MedPath
FDA Approval

OLOPATADINE HYDROCHLORIDE

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
June 7, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Olopatadine(1.11 mg in 1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

RPK Pharmaceuticals, Inc.

RPK Pharmaceuticals, Inc.

147096275

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

OLOPATADINE HYDROCHLORIDE

Product Details

NDC Product Code
53002-0510
Application Number
ANDA206306
Marketing Category
ANDA (C73584)
Route of Administration
OPHTHALMIC
Effective Date
April 26, 2023
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
Code: 2XG66W44KFClass: ACTIMQuantity: 1.11 mg in 1 mL
SODIUM PHOSPHATE, DIBASIC, ANHYDROUSInactive
Code: 22ADO53M6FClass: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACT
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7Class: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
© Copyright 2025. All Rights Reserved by MedPath